AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2015

Jun 8, 2015

34975_dirs_2015-06-08_56e700d5-1fd0-4b80-9bb6-c6bffd766600.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2015-06-04

Reporting Person: Sibony Yoav (VP - Global Sales)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-04	Common Stock	A	10335	$0.00	Acquired	10335	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-04	Stock option (right to buy)	$5.56	A	19500	Acquired	2025-06-04	Common Stock, par value $0.01 per share (19500)	Direct

Footnotes

F1: Represents a deferred stock award of 10,335 restricted stock units which shall vest in four equal installments on January 1, 2016, 2017, 2018 and 2019.

F2: The options vest in four equal installments on January 1, 2016, 2017, 2018 and 2019.